STOCK TITAN

AKANDA CORP - AKAN STOCK NEWS

Welcome to our dedicated page for AKANDA news (Ticker: AKAN), a resource for investors and traders seeking the latest updates and insights on AKANDA stock.

About Akanda Corp

Akanda Corp (NASDAQ: AKAN) is an international medical cannabis and wellness company dedicated to improving lives through high-quality, affordable cannabis-based products. Headquartered in London, UK, Akanda operates across the cannabis value chain, encompassing cultivation, manufacturing, and distribution. With a mission to provide safe and reliable cannabis solutions, the company focuses on medical-grade cannabis and wellness products, adhering to stringent regulatory standards and leveraging innovative technologies.

Core Business Segments

Cultivation: Akanda's cultivation activities are centered in Portugal through its subsidiary Holigen, which operates an EU GMP-certified indoor grow facility. This facility ensures compliance with European Union Good Manufacturing Practices, enabling the production of premium medical-grade cannabis for the European and international markets.

Distribution: In the United Kingdom, Akanda's subsidiary, CanMart Ltd, is a fully licensed importer and distributor of Cannabis-Based Products for Medicinal Use (CBPMs). CanMart supplies pharmacies and clinics while also offering third-party import and distribution services for Schedule 2 products, including CBPMs.

Corporate: Akanda's corporate segment manages administrative functions and strategic initiatives, including partnerships, acquisitions, and technological advancements to support the broader group.

Technological Innovation

Recognizing the transformative potential of technology, Akanda is actively exploring blockchain and artificial intelligence (AI) applications within the cannabis industry. Blockchain technology enhances supply chain transparency by securely tracking products from cultivation to sale, while AI-driven algorithms optimize product customization and strain development. These innovations position Akanda at the forefront of the cannabis-tech convergence.

Strategic Partnerships and Market Position

Akanda has established strategic alliances with industry leaders such as Cookies, Cansativa Group, and Cellen Life Sciences. These partnerships bolster its seed-to-patient supply chain and expand its market reach across Europe and North America. Additionally, Akanda's entry into the Canadian and German markets underscores its commitment to growth and global market leadership.

Commitment to Sustainability and Compliance

Akanda prioritizes sustainability and compliance in its operations. Its EU GMP-certified facilities and adherence to local and international regulations ensure product quality and safety. The company's focus on sustainable business practices aligns with its mission to deliver value to consumers and stakeholders alike.

Future Outlook

With a strategic emphasis on innovation, market expansion, and regulatory compliance, Akanda is well-positioned to capitalize on the growing global cannabis market. The company's integration of advanced technologies and its focus on medical and wellness applications highlight its commitment to shaping the future of the cannabis industry.

Rhea-AI Summary
Akanda Corp. announces a securities purchase agreement with accredited investors, offering 280,851 common shares at $0.406 per share and pre-funded warrants to purchase 1,462,991 common shares. The gross proceeds are estimated to be approximately $708,000 before deducting financial advisor fees and other offering expenses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Akanda Corp. has entered into an Amended Non-Binding Letter of Intent with Somai Pharmaceuticals Ltd. for the sale of its Portuguese subsidiary, RPK. The purchase price has been amended to USD $2,000,000 from USD $2,700,000, which includes all current liabilities of RPK, approximately 4,000,000 Euros. A deposit of USD $500,000 will be placed in an escrow account, with the remainder due upon successful completion of the transaction. The closing of the proposed transaction will be subject to customary due diligence, representations and warranties, covenants, indemnities, and closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
none
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) received a 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement. The company now has until July 1, 2024, to achieve compliance. If not, the shares may be subject to delisting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.12%
Tags
none
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) appoints Charn Deol as the new Chief Financial Officer, bringing over 35 years of financial markets experience. The company aims to leverage his expertise to navigate the early-stage European and worldwide cannabis markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
none
-
Rhea-AI Summary
Akanda Corp. announces agreement to purchase farming land and related operations and licenses for $1.8 million. The company plans to develop THC and CBD facilities at the site and will make additional payments based on milestones achieved.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.12%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.68%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.94%
Tags
none
-
Rhea-AI Summary

Akanda Corp. (NASDAQ: AKAN) announced on March 27, 2023, that it has regained compliance with the Nasdaq minimum bid price requirement after a notification letter indicated it had met the criteria. The company had previously received a non-compliance notice on September 27, 2022, due to its stock price falling below $1.00 for 30 consecutive business days. Following a compliance period of 180 days, Akanda's shares have maintained a closing bid price of at least $1.00 for the last 12 business days, thus closing the matter with Nasdaq.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3%
Tags
none
Rhea-AI Summary

Akanda Corp. (NASDAQ: AKAN) announced a 1-for-10 reverse stock split, effective March 9. Following the split, every 10 shares will convert to one share, with trading continuing on the Nasdaq under the same symbol. The CUSIP number for ordinary shares will change to 00971M205. This decision has been approved by the board and shareholders, and articles of amendment have been filed with the Ontario Ministry of Government and Consumer Services. The reverse split aims to adjust the share structure without altering shareholders' percentage interest in the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.42%
Tags
none

FAQ

What is the current stock price of AKANDA (AKAN)?

The current stock price of AKANDA (AKAN) is $1.69 as of February 28, 2025.

What is the market cap of AKANDA (AKAN)?

The market cap of AKANDA (AKAN) is approximately 2.4M.

What does Akanda Corp specialize in?

Akanda Corp specializes in the cultivation, manufacturing, and distribution of medical-grade cannabis and wellness products, with a focus on regulatory compliance and innovative technologies.

Where does Akanda operate?

Akanda operates in Europe, primarily in the UK and Portugal, and is expanding into North America and other international markets.

What sets Akanda apart from competitors?

Akanda's differentiators include its EU GMP-certified facilities, strategic partnerships, blockchain and AI-driven innovations, and a comprehensive seed-to-patient supply chain.

How does Akanda use blockchain technology?

Akanda leverages blockchain technology to enhance supply chain transparency, ensuring secure tracking of cannabis products from cultivation to sale.

What is Akanda's role in the UK cannabis market?

Through its subsidiary CanMart Ltd, Akanda is a leading importer and distributor of Cannabis-Based Products for Medicinal Use (CBPMs) in the UK, supplying pharmacies and clinics.

Is Akanda involved in recreational cannabis markets?

While Akanda primarily focuses on medical cannabis, it is exploring opportunities in recreational markets, particularly in Germany and Canada.

What are Akanda's growth strategies?

Akanda's growth strategies include market expansion, technological innovation, strategic partnerships, and acquisitions in key cannabis markets.

What is Akanda's commitment to sustainability?

Akanda emphasizes sustainability through its compliance with EU GMP standards, environmentally friendly practices, and a focus on delivering safe, high-quality products.
AKANDA CORP

Nasdaq:AKAN

AKAN Rankings

AKAN Stock Data

2.38M
1.98M
1.65%
0%
2.19%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
New Romney